Search Result "high-risk neuroblastomas"
High-Risk Neuroblastoma: Poor Outcomes Despite Aggressive MultimodalTherapy
Journal: Current Cancer Therapy Reviews
Volume: 18 Issue: 1 Year: 2022 Page: 14-40
Author(s): Adil Abdelhamed Abbas,Alaa Mohammed Noor Samkari
Current Management of Neonatal Neuroblastoma
Journal: Current Pediatric Reviews
Volume: 11 Issue: 3 Year: 2015 Page: 179-187
Author(s): Rodrigo B. Interiano,Andrew M. Davidoff
Apoptosis Pathways and Neuroblastoma Therapy
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 4 Year: 2009 Page: 430-435
Author(s): S. Fulda
Targeting Histone Deacetylases in Neuroblastoma
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 4 Year: 2009 Page: 436-447
Author(s): O. Witt, H. E. Deubzer, M. Lodrini, T. Milde, I. Oehme
Novel Drugs for Neuroblastoma
Journal: Drug Design Reviews - Online (Discontinued)
Volume: 2 Issue: 7 Year: 2005 Page: 527-535
Author(s): Elzbieta Izbicka, Tadeusz Izbicki
Targeting Focal Adhesion Kinase in Neuroblastoma
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 1 Year: 2010 Page: 714-721
Author(s): Lauren Gillory, Elizabeth A. Beierle
Research Advances in Neuroblastoma Immunotherapy
Journal: Current Pediatric Reviews
Volume: 5 Issue: 2 Year: 2009 Page: 112-117
Author(s): Latania Y. Booker, Titilope A. Ishola, Kanika A. Bowen, Dai H. Chung
The DNMT3B Inhibitor Nanaomycin A as a Neuroblastoma TherapeuticAgent
Journal: Current Cancer Drug Targets
Volume: 23 Issue: 11 Year: 2023 Page: 837-842
Author(s):
Cellular Immunotherapy for Neuroblastoma: A Review of Current Vaccine and Adoptive T Cell Therapeutics
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 4 Year: 2009 Page: 424-429
Author(s): C. U. Louis, M. K. Brenner
Oncoproteomics of Neuroblastoma: A Blueprint for Future Progress
Journal: Current Proteomics
Volume: 7 Issue: 1 Year: 2010 Page: 1-14
Author(s): Hari R. Kumar, Xiaoling Zhong, Robert J. Hickey, Linda H. Malkas, John A. Sandoval